Too Many Veterans With HIV Prescribed Inappropriate BP Medications

HIV patients on anti-retroviral therapy are at increased risk for cardiovascular events, heightening the importance of preventive care. Now, new research has found that selection of blood pressure medication is critically important for this group and can have a significant effect on risk of cardiovascular events or even death.

New Focus in the Fight to Reduce CV Risks in Type 2 Diabetes

At one point, intensive glycemic control was seen as a magic bullet to keep Type 2 diabetes patients from developing cardiovascular disease. That approach faded, however, when VA research cautioned that any benefits of intensive therapy must be weighed against adverse effects such as hypoglycemia and weight gain. Now the focus has shifted to better medication selection, with guidelines suggesting that, for Type 2 diabetes patients who have cardiovascular disease or are at high risk for it, therapy including an SGLT-2 inhibitor or GLP-1 RA should be considered as optimal treatment.